IMMUNITYBIO, INC. Stock Repurchased During Period, Value
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- IMMUNITYBIO, INC. stock repurchased during period, value for the quarter ending 2016-09-30 was $2.57M.
- IMMUNITYBIO, INC. stock repurchased during period, value for the quarter ending 2016-06-30 was $6.77M.
- IMMUNITYBIO, INC. stock repurchased during period, value for the quarter ending 2016-03-31 was $2.55M.
- IMMUNITYBIO, INC. stock repurchased during period, value for the quarter ending 2015-12-31 was $0.00.
- IMMUNITYBIO, INC. stock repurchased during period, value for fiscal 2019 was $2.50M.
- IMMUNITYBIO, INC. stock repurchased during period, value for fiscal 2015 was $4.80M.
| Period end | Stock Repurchased During Period, Value 3 month | Stock Repurchased During Period, Value 12 month |
|---|---|---|
| 2019-12-31 | $2.50M 10-K · filed 2022-03-01 | |
| 2016-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $11.90M derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | $6.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $9.32M derived: sum of 4 quarters · filed 2016-08-15 |
| 2016-03-31 | $2.55M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.80M 10-K · filed 2016-03-30 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |